ON DEMAND

Online education and training provided through programs, modules, and presentations

The Latest

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.
By MCL Education • September 9, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture,” Jennifer Storlie, will discusse professionalism as a journey that encompasses attitudes, behaviors, and actions that impact how service is delivered.
By MCL Education • August 27, 2019
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.
By MCL Education • August 12, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture” learn what it takes to develop an onboarding program for new supervisors and managers while exploring the importance of supporting your new leaders.
By MCL Education • July 24, 2019
In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.
By MCL Education • July 1, 2019
PACE / State of CA / State of FL
This month’s “Virtual Lecture” discusses bleeding and clotting disorders with a focus on molecular testing.
By MCL Education • June 20, 2019
Antibodies to aquaporin-4 and myelin oligodendrocyte glycoprotein (MOG) are recently described biomarkers seen in a subset of atypical optic neuritis which have revolutionized our understanding of the condition. In this “Hot Topic,” my colleague, Dr. John Chen, will review these advances and how they impact the clinical care of our patients with optic neuritis.
By MCL Education • June 3, 2019
PACE
In this month’s “Virtual Lecture,” Kevin Halling, M.D., Ph.D., will review basic cancer genetics concepts and discuss examples of how RNA sequencing can be used to detect clinically relevant alterations in tumors such as gene fusions, point mutations, tumor mutation burden, and gene expression of individual genes or sets of genes.
By MCL Education • May 30, 2019